Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-08-16 HIGGINS JOHN L Chief Executive Officer Option exercise +3,007 $14.47 $44K 110,426
2018-08-16 HIGGINS JOHN L Chief Executive Officer Sale −21,507 $241.33 $5.2M 88,919
2018-08-16 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −3,007 171,993
2018-08-16 Patel Sunil Director Option exercise +5,000 $9.60 $48K 44,806
2018-08-16 Patel Sunil Director Option exercise +7,335 $10.12 $74K 52,141
2018-08-16 Patel Sunil Director Option exercise +7,335 $12.53 $92K 59,476
2018-08-16 Patel Sunil Director Option exercise +7,335 $32.30 $237K 66,811
2018-08-16 Patel Sunil Director Sale −42,287 $240.05 $10.2M 24,524
2018-08-16 Patel Sunil Director Option exercise · Non-Qualified Stock Option (right to buy) −5,000 0
2018-08-16 Patel Sunil Director Option exercise · Non-Qualified Stock Option (right to buy) −7,335 0
2018-08-16 Patel Sunil Director Option exercise · Non-Qualified Stock Option (right to buy) −7,335 0
2018-08-16 Patel Sunil Director Option exercise · Non-Qualified Stock Option (right to buy) −7,335 0
2018-08-06 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −836 $226.74 $190K 13,559
2018-07-02 KOZARICH JOHN W Director Sale −2,500 $207.48 $519K 28,642
2018-06-29 Korenberg Matthew E EVP,Finance & Strategy and CFO Other acquisition +180 $117.84 $21K 14,395
2018-06-29 Berkman Charles S SVP, Gen. Counsel & Secretary Other acquisition +180 $117.84 $21K 27,763
2018-06-19 Sabba Stephen L Director Grant or award +493 26,856
2018-06-19 Sabba Stephen L Director Grant or award · Non-Qualified Stock Option (right to buy) +2,474 2,474
2018-06-19 Aryeh Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +2,474 2,474
2018-06-19 Davis Todd C Director Grant or award · Non-Qualified Stock Option (right to buy) +2,474 2,474

Page 50 of 55 · 1,097 trades